sexually transmitted diseases david w. haas, m.d. division of infectious diseases vanderbilt...

47
Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Upload: scot-perkins

Post on 21-Jan-2016

221 views

Category:

Documents


4 download

TRANSCRIPT

Page 1: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Sexually Transmitted Diseases

David W. Haas, M.D.Division of Infectious Diseases

Vanderbilt University School of MedicineNashville, Tennessee

Page 2: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 3: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Case Presentation

• 19 YO male c/o burning on urination, yellow discharge on underwear.

• Has otherwise been well.

– What are likely diagnoses?

– What tests should be done?

– What treatment may be needed?

– Anything else to do?

Page 4: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 5: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Gonococcal Urethritis

• Incubation 1-10 days

• Can’t differentiate from chlamydia by symptoms

• Most infections are symptomatic

• May persist without continued symptoms

Page 6: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Acute Epididymitis

• Young men

– Chlamydia (most common)

– Gonococcus

• Old men

– Gram (-) enterics

– Pseudomonas

Page 7: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Localized Gonococcal Infections

• Anorectal infection

– Culture often (+) in women with cervical GC

– Treatment failures detected at rectum

• Pharyngeal infection

– Orogenital exposure

• Pelvic inflammatory disease

– Cervix doesn’t predict upper tract GC

– 20% risk of infertility

• Perihepatitis (Fitz-Hugh-Curtis syndrome)

Page 8: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 9: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Disseminated Gonococcal Infection

Arthritis-dermatitis syndrome

Septic arthritis

Joint involvement

Number several 1 or 2

Sites Knee, elbow, wrist, ankle

Knee, elbow, wrist, ankle

Character Tenosynovitis Frank arthritis

Cells <20,000 WBC/mm3 >50,000WBC/mm3

Culture Negative Often positive

Papules/pustules 5-40 Absent

Blood culture Often positive Negative

Page 10: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 11: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 12: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 13: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Diagnosis of Gonorrhea

• Culture– Rapidly inoculate media– Thayer-Martin, others

• DNA probes or DNA amplification– If used, culture unnecessary

• Gram stain– Gram (-) diplococci– Many leukocytes

Page 14: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 15: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Treatment of Uncomplicated Gonorrhea (urethra, cervix, pharynx, rectum)

• Ceftriaxone (125mg IM x 1 dose) OR• Cefixime (400mg PO x 1 dose) OR• Cefpodoxime (400mg PO x 1 dose) OR• Ciprofloxacin (500mg PO x 1 dose) OR• Gatifloxacin (400mg PO x 1 dose) OR• Levofloxacin (250mg PO x 1 dose)

+• Azithromycin 1g po x 1 dose OR• Doxycycline 100mg q12h po x 7 days

Page 16: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Treatment of GonorrheaGeneral Considerations

• Reculture all (+) sites at 4-7 days• Consider reculture os rectal canal in women• Examine and culture sexual contacts• Treat sexual contacts regardless

Page 17: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Chlamydia trachomatisGenital Disease

• Urethritis in men

– Isolated with 20% of GC cases

– Isolated in 40% of NGU

– Asymptomatic infection common

• Epididymitis

• Cervicitis

• Pelvic inflammatory disease

– Infertility risk 10%

– Perihepatitis

Page 18: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Diagnosing C. trachomatis Infection

• Gram stain 4 WBC’s per oil-immersion field– No organisms seen

• Rapid methods– DNA probes or PCR

• Culture– Costly, not generally done

Page 19: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Case Presentation

• 19 YO male c/o burning on urination, yellow discharge on underwear.

• Has otherwise been well.

– What are likely diagnoses?

– What tests should be done?

– What treatment may be needed?

– Anything else to do?

Page 20: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 21: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Syphilis

Stage

• Primary

• Secondary

• Latent

• Late

Onset

3 weeks

2-8 weeks

>8 weeks

years

Page 22: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

“Classic” Syphilitic Chancre

• Painless

• Raised borders

• No exudate

• At inoculation site

• Rarely seen by physician

Page 23: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 24: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 25: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 26: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Secondary Syphilis

• Rash

– Variable, palms & soles

• Fever

• Diffuse lymphadenopathy

• Patchy alopecia

• Mucous patches

• Condyloma lata

Page 27: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 28: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 29: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 30: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 31: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 32: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 33: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Darkfield Examination for Syphilis

1. Abrade lesion with dry gauze

2. Obtain serous exudate

3. Place on slide with coverslip

4. View motile spirochetes

• Great for primary and secondary syphilis, not for oral lesions

Page 34: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 35: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Syphilis Serology

Primary Secondary Late

Nontreponemal tests

(VDRL & RPR)75% 99%

1%

(if treated)

Specific treponemal tests

(FTA-Abs,

MHA-TP, TPHA)

75% 100% 95%

Page 36: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Who with Latent SyphilisNeeds a Spinal Tap?

• Neurologic symptoms

• Failure of RPR to fall with therapy

• RPR 1:32

• Inability to give penicillin

If CSF abnormal, treat for neurosyphilis

Page 37: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Treating Syphilis

• Primary and Secondary

– Benzathine PCN 2.4 million units IM x 1

– (Ceftriaxone 1g qd IV or IM x 8-10 d)

– (Doxycycline 100mg q12h x 14 d)

– Anticipate Jarisch-Herxheimer

• Latent (>1 year duration)

– Benzathine PCN 2.4mil units IM weekly x 3

– (Doxycycline 100mg q12h x 28 d)

Page 38: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Treating Neurosyphilis

– Pen G 2-4 million units IV q4h x 10-14 d

– (Procaine Pen G 2.4 mil units IM q24h + probenacid 500 mg PO qid x 14 days)

– (Ceftriaxone 1g IV or IM qd x 14 d)

Page 39: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 40: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Genital Herpes - Initial Episode

• Painful vesicles or pustules which ulcerate

• Fever, headache, myalgias• Tender inguinal adenopathy• Extragenital vesicles common• Pharyngitis, aseptic meningitis, urethritis

occasional

Page 41: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 42: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Genital Herpes - Recurrent

• 90% recur in first year

• Average 5 per year initially

• Less severe than first episode

• Avoid sex until lesions heal

Page 43: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Diagnosing Genital Herpes

• Diagnosis often clinical• Cytology (Tzank prep) shows

– Scrape lesion– Spear to microscope slide– Stain with Pap or Wright-Giemsa– See multinucleated giant cells

• Culture– Swab lesion– To viral transport media– Cytopathic effect in 1-4 days

Page 44: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee
Page 45: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Treating Genital Herpes• Initial

– Acyclovir 400mg po q8h x 7-10 days– Valacyclovir 1g po q12h x 10 days– Famciclivir 250mg po q8h x 7-10 days

• Recurrent (Often not treated)– Acyclovir 400mg q8h x 5 days– Valacyclovir 500mg po q12h x 3 days– Famciclivir 125mg po q12h x 5 days

• Chronic suppression– Acyclovir 400mg q12h– Valacyclovir 1g po q24h– Famciclivir 250mg po q12h

Page 46: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee

Sexually Transmitted Diseases

Page 47: Sexually Transmitted Diseases David W. Haas, M.D. Division of Infectious Diseases Vanderbilt University School of Medicine Nashville, Tennessee